Race, Ethnicity, and Clinical Utility in Cancer Genetics - Webinar - Ambry Genetics

Explore the intersection of race, ethnicity, and clinical utility in cancer genetics through a detailed presentation of recent research findings. Delve into a study examining racial and ethnic differences in cancer genetic testing results for women with breast cancer. Gain insights into opportunities for improving genetic testing utility in populations facing health inequalities. Learn from Holly LaDuca, MS, CGC, Associate Director of Clinical Research at Ambry Genetics, as she shares her expertise in translational research application and clinical implementation of polygenic risk scores. Benefit from a comprehensive discussion covering topics such as defining race and ethnicity, understanding cancer health disparities in racial/ethnic minorities, and analyzing cancer risk associations by subtype. Examine the limitations of current research and classification methods in clinical genetics. Enhance your knowledge of diversity measures in genetic testing and their impact on healthcare outcomes.

Intro
Defining race & ethnicity
Lack of standard definitions/protocols for diversity measures in clinical genetics
Race & ethnicity, as defined by the Office of Management and Budget (OMB)
Examples of cancer health disparities in racial/ethnic minorities
Checkpoint #1
Race/ethnicity classification
Checkpoint #2
Cancer risk associations by subtype
Checkpoint #3
Limitations
Study team